Health

Results: 3781-3792 of 8784

PR Newswire associated0

PeptiGrowth Inc. is Launching a Novel Synthetic Peptide: KGF alternative peptide (FGFR2b agonist)

ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights

SINOVAC Announces Decision to Declare Cash Dividend

PR Newswire associated0

Kindeva Appoints Daniel J. Speciale as the New Chief Financial Officer (CFO)

New services for patients under record pharmacy funding deal

Following a planned interim analysis in the PROCEED trial Lundbeck expands the dose finding to intravenous administration of Lu AG09222 in migraine prevention

Sobi publishes Annual and sustainability report for 2024

Business Wire logo

Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer

PR Newswire associated0

Human Frontier Science Program: Fellowships Awarded to 60 Pioneering Postdoctoral Scientists from 25 Nations

OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod

Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

Business Wire logo

ABEC Unveils Breakthrough Single Use Bioreactor Technology for Cell Therapy Manufacturing